These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 18791329
21. Coronary artery disease following bone marrow transplantation. Chan KW, Taylor GP, Shepherd JD, Shepherd WE. Bone Marrow Transplant; 1989 May; 4(3):327-30. PubMed ID: 2659118 [Abstract] [Full Text] [Related]
23. Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT). Oshima Y, Takahashi S, Nagayama H, Nishiwaki K, Kobayashi Y, Tojo A, Okamoto S, Tani K, Ozawa K, Wakabayashi T, Sato N, Kobayashi S, Nakamura K, Ohya Y, Nukina N, Kanazawa I, Asano S. Bone Marrow Transplant; 1997 Apr; 19(7):737-40. PubMed ID: 9156252 [Abstract] [Full Text] [Related]
24. [A case of eosinophilic pneumonia which occurred after bone marrow transplantation for acute myeloid leukemia]. Furuta K, Taki M, Murase H, Nakagawa A, Nishiyama H, Nohgawa M. Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):20-4. PubMed ID: 21384677 [Abstract] [Full Text] [Related]
25. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion. Levenga H, Woestenenk R, Schattenberg AV, Maas F, Jansen JH, Raymakers R, De Mulder PH, van de Wiel-van Kemenade E, Schaap N, de Witte T, Dolstra H. Bone Marrow Transplant; 2007 Sep; 40(6):585-92. PubMed ID: 17637687 [Abstract] [Full Text] [Related]
26. Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose. Fozza C, Szydlo RM, Abdel-Rehim MM, Nadal E, Goldman JM, Apperley JF, Dazzi F. Br J Haematol; 2007 Mar; 136(6):833-6. PubMed ID: 17341269 [Abstract] [Full Text] [Related]
27. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect. Alyea EP. Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989 [Abstract] [Full Text] [Related]
28. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation. Loren AW, Porter DL. Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156 [Abstract] [Full Text] [Related]
29. Exanthema and enanthema in graft versus host disease (GVHD). Suzuki M, Kikkawa Y, Hasegawa T, Kaneko F. Fukushima J Med Sci; 1993 Dec; 39(2):101-7. PubMed ID: 7927132 [Abstract] [Full Text] [Related]
31. [Secondary eosinophilia in a patient with hypereosinophilic syndrome after allogeneic bone marrow transplantation from a sibling donor]. Ito C, Tsuboi K, Yoshiba F, Kubota N, Tazume K, Oki M, Tsuchiya T, Ohmachi K, Kikuchi A, Shimakura Y, Ando K, Kishi K, Yonekura S, Hotta T. Rinsho Ketsueki; 2001 Jun; 42(6):496-501. PubMed ID: 11505529 [Abstract] [Full Text] [Related]
32. Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab. Kato I, Umeda K, Awaya T, Yui Y, Niwa A, Fujino H, Matsubara H, Watanabe K, Heike T, Adachi N, Endo F, Mizukami T, Nunoi H, Nakahata T, Adachi S. Pediatr Blood Cancer; 2010 Feb; 54(2):329-31. PubMed ID: 19890900 [Abstract] [Full Text] [Related]
33. Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation. Hartwig M, Weigel S, Bernig T, Bader P, Dölken R, Beck J. Pediatr Hematol Oncol; 2007 Mar; 24(2):137-40. PubMed ID: 17454780 [Abstract] [Full Text] [Related]
34. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. Olson KA, West K, McCarthy PL. Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567 [Abstract] [Full Text] [Related]
35. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation. Prigozhina TB, Elkin G, Khitrin S, Slavin S. Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241 [Abstract] [Full Text] [Related]
36. Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies. Owaidah TM. Saudi Med J; 2003 Feb; 24(2):138-41. PubMed ID: 12682675 [Abstract] [Full Text] [Related]
37. Staphylococcal scalded skin syndrome mimicking acute graft-vs-host disease in a bone marrow transplant recipient. Goldberg NS, Ahmed T, Robinson B, Ascensao J, Horowitz H. Arch Dermatol; 1989 Jan; 125(1):85-7. PubMed ID: 2642684 [Abstract] [Full Text] [Related]
38. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML. Pulsipher MA, Adams RH, Asch J, Petersen FB. Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663 [Abstract] [Full Text] [Related]
39. An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion. Kottaridis PD, Ketley N, Peggs K, Chakraverty R, Ralleigh G, Shaw P, Pezzella F, Goldstone AH, Devereux S, Mackinnon S. Bone Marrow Transplant; 1999 Oct; 24(7):807-9. PubMed ID: 10516687 [Abstract] [Full Text] [Related]